We are live on ! Find out more
TTOO

T2 Biosystems, Inc
TTOO

Delisted

TTOO was delisted on the 11th of February, 2025.

Back to rankings

36 hedge funds and large institutions have $243M invested in T2 Biosystems, Inc in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 1

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

24% more funds holding

Funds holding: 29 → 36 (+7)

8% more capital invested

Capital invested by funds: $224M → $243M (+$18.3M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
36
Holders Change
+7
Holders Change %
+24.14%
% of All Funds
0.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
13
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$4.37M
2
GGHC
Gilder Gagnon Howe & Co
New York
+$2.64M
3
CCI
Columbus Circle Investors
+$824K
4
Northern Trust
Northern Trust
Illinois
+$742K
5
Citigroup
Citigroup
New York
+$495K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.9M
2
SIM
Spark Investment Management
New York
-$284K
3
SO
STRS Ohio
Ohio
-$36K
4
Bank of America
Bank of America
North Carolina
-$23K
5
TRCT
Tower Research Capital (TRC)
New York
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$66.5M – – –
AC
2
Aisling Capital
New York
$48.5M – – –
PVMCV
3
Polaris Venture Management Co V
Massachusetts
$45.7M – – –
GGHC
4
Gilder Gagnon Howe & Co
New York
$27.2M +$2.64M +32 +13%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$16.6M +$4.37M +53 +45%
HCS
6
Harvest Capital Strategies
California
$6.16M +$247K +3 +5%
FCMI
7
Foresite Capital Management II
California
$4.39M +$3.79M +46 New
Fidelity Investments
8
Fidelity Investments
Massachusetts
$4.19M -$11.9M -144 -77%
EIM
9
Essex Investment Management
Massachusetts
$3.23M +$330K +4 +13%
BFA
10
BlackRock Fund Advisors
California
$3.16M +$330K +4 +14%
Vanguard Group
11
Vanguard Group
Pennsylvania
$2.96M +$412K +5 +19%
RCM
12
RA Capital Management
Massachusetts
$2.65M – – –
TM
13
Tiger Management
New York
$1.75M – – –
BIT
14
BlackRock Institutional Trust
California
$1.21M – – –
Northern Trust
15
Northern Trust
Illinois
$1.15M +$742K +9 +300%
CCI
16
Columbus Circle Investors
$997K +$824K +10 New
State Street
17
State Street
Massachusetts
$879K +$82.4K +1 +13%
WC
18
Woodstock Corp
Massachusetts
$559K +$495K +6 New
Citigroup
19
Citigroup
New York
$553K +$495K +6 New
TCIM
20
TIAA CREF Investment Management
New York
$543K +$247K +3 +100%
USAA
21
United Services Automobile Association
Texas
$537K +$247K +3 +100%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$536K +$82.4K +1 +20%
Morgan Stanley
23
Morgan Stanley
New York
$472K – – –
CCM
24
Cadence Capital Management
Massachusetts
$409K +$330K +4 New
BIM
25
BlackRock Investment Management
Delaware
$329K – – –
1
2

TTOO Hedge Fund Activity: Q4 2014 in Review

36 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2014, worth a combined $243M — up 8.1% from $224M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TTOO positions and 1 closed out — a net gain of 7 holders — while 13 added to existing stakes and 1 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $4.37M. The largest seller was Fidelity Investments, cutting an estimated $11.9M.

  • 36 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2014, up from 29 in Q3 2014.
  • Funds reported $243M of T2 Biosystems, Inc stock for Q4 2014, up 8.1% quarter-over-quarter.
  • 8 funds opened new T2 Biosystems, Inc positions in Q4 2014 and 1 closed out, a net change of +7 holders.
  • The largest T2 Biosystems, Inc buyer in Q4 2014 was Wellington Management Group, an estimated $4.37M added.
  • The largest T2 Biosystems, Inc seller in Q4 2014 was Fidelity Investments, an estimated $11.9M sold.

Based on aggregated 13F filings for Q4 2014.